309 related articles for article (PubMed ID: 38112998)
1. RNA Modifications in Cancer Stem Cell Biology.
Cerneckis J; Cui Q; Liu W; Shi Y
Cancer Treat Res; 2023; 190():25-47. PubMed ID: 38112998
[TBL] [Abstract][Full Text] [Related]
2. RNA N
Zhang Z; Zhang C; Luo Y; Zhang G; Wu P; Sun N; He J
Clin Transl Med; 2021 Sep; 11(9):e525. PubMed ID: 34586737
[TBL] [Abstract][Full Text] [Related]
3. RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy.
Kumari S; Kumar S; Muthuswamy S
J Cancer Res Clin Oncol; 2023 Apr; 149(4):1621-1633. PubMed ID: 35796777
[TBL] [Abstract][Full Text] [Related]
4. RNA editing-dependent epitranscriptome diversity in cancer stem cells.
Jiang Q; Crews LA; Holm F; Jamieson CHM
Nat Rev Cancer; 2017 Jun; 17(6):381-392. PubMed ID: 28416802
[TBL] [Abstract][Full Text] [Related]
5. Post-transcriptional regulations of cancer stem cell homeostasis.
Berabez N; Durand S; Gabut M
Curr Opin Oncol; 2019 Mar; 31(2):100-107. PubMed ID: 30562314
[TBL] [Abstract][Full Text] [Related]
6. Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics.
Uddin MB; Wang Z; Yang C
Theranostics; 2020; 10(7):3164-3189. PubMed ID: 32194861
[TBL] [Abstract][Full Text] [Related]
7. The role of m
Nombela P; Miguel-López B; Blanco S
Mol Cancer; 2021 Jan; 20(1):18. PubMed ID: 33461542
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cell heterogeneity: origin and new perspectives on CSC targeting.
Eun K; Ham SW; Kim H
BMB Rep; 2017 Mar; 50(3):117-125. PubMed ID: 27998397
[TBL] [Abstract][Full Text] [Related]
9. N6-methyladenosine (m6A) RNA modification in cancer stem cells.
Ma Z; Ji J
Stem Cells; 2020 Sep; ():. PubMed ID: 32985068
[TBL] [Abstract][Full Text] [Related]
10. mRNA modification orchestrates cancer stem cell fate decisions.
Liang W; Lin Z; Du C; Qiu D; Zhang Q
Mol Cancer; 2020 Feb; 19(1):38. PubMed ID: 32101138
[TBL] [Abstract][Full Text] [Related]
11. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
12. Cancer Stem Cell Markers in Relation to Patient Survival Outcomes: Lessons for Integrative Diagnostics and Next-Generation Anticancer Drug Development.
Dzobo K; Ganz C; Thomford NE; Senthebane DA
OMICS; 2021 Feb; 25(2):81-92. PubMed ID: 33170084
[TBL] [Abstract][Full Text] [Related]
13. An emerging role for cellular crosstalk in the cancer stem cell niche.
Oshimori N; Guo Y; Taniguchi S
J Pathol; 2021 Jul; 254(4):384-394. PubMed ID: 33634866
[TBL] [Abstract][Full Text] [Related]
14. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness.
Ma Y; Shen N; Wicha MS; Luo M
Cells; 2021 Sep; 10(9):. PubMed ID: 34572067
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
16. The expanding roles of long non-coding RNAs in the regulation of cancer stem cells.
Ma Z; Wang YY; Xin HW; Wang L; Arfuso F; Dharmarajan A; Kumar AP; Wang H; Tang FR; Warrier S; Tergaonkar V; Sethi G
Int J Biochem Cell Biol; 2019 Mar; 108():17-20. PubMed ID: 30630112
[TBL] [Abstract][Full Text] [Related]
17. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
Safa AR
Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
[TBL] [Abstract][Full Text] [Related]
18. Dynamic regulation of cancer stem cells and clinical challenges.
Ni C; Huang J
Clin Transl Oncol; 2013 Apr; 15(4):253-8. PubMed ID: 22926945
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia in solid tumors: a key promoter of cancer stem cell (CSC) resistance.
Najafi M; Farhood B; Mortezaee K; Kharazinejad E; Majidpoor J; Ahadi R
J Cancer Res Clin Oncol; 2020 Jan; 146(1):19-31. PubMed ID: 31734836
[TBL] [Abstract][Full Text] [Related]
20. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
